News
/news
socrateshealthsolutions.comCrawled Oct 14, 2026
Socrates Health Solutions has achieved progress in its proprietary non-invasive glucose monitoring technology. The company secures backing from notable shareholders, including the NFL Players Association and OneTeam Partners. This development aims to improve diabetes management without traditional invasive methods.
Socrates Health Solutions appoints John Maynard as special advisor to guide its noninvasive blood glucose monitoring device, Socrates Companion™. Maynard contributes over 25 years of experience in developing and commercializing non-invasive medical diagnostics. The move aims to strengthen the company’s expertise in bringing innovative glucose monitoring solutions to market.
Socrates Health Solutions validates its **Socrates Companion™** device, which now measures blood glucose levels noninvasively across broader ranges for diabetic patients. Testing on human subjects in **March 2018** confirmed the device’s expanded functionality without requiring finger-prick samples. The solution targets improved convenience and monitoring accuracy for diabetes management.
Socrates Health Solutions adds Douglas Sutherland to its Board of Directors. Sutherland, a diabetes-focused investor and former global executive, currently serves as Non-executive Chairman of Regus plc. The company develops the Socrates Companion™, a noninvasive blood glucose monitoring device designed to be pain-free, accurate, and affordable.
Socrates Health Solutions secures a patent for a novel technique in its noninvasive blood glucose monitoring system. The innovation aims to improve accuracy and user experience without requiring traditional finger-prick tests. The company continues to develop wearable health technology for diabetes management.
Green Park & Golf Ventures has invested in Socrates Health Solutions. The venture capital firm finalizes a strategic funding deal with the health-focused company. Socrates Health Solutions operates in the wellness and health solutions sector, though specific details of the investment or company operations are not disclosed in the announcement.